Sacral neuromodulation and pregnancy: Results of a national survey carried out for the neuro‐urology committee of the French Association of Urology (AFU)

Abstract

In 27 pregnancies established during SNM for LUTS, 18.5% of patients deactivated their case before pregnancy and the others switched it off during the first trimester. Three-quarters of women with CRU had urinary infection. No adverse effects on fetuses were found. SNM effectiveness deteriorated in 20% cases after childbirth.